Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

NLRP1, a regulator of innate immunity associated with vitiligo.

D'Osualdo A, Reed JC.

Pigment Cell Melanoma Res. 2012 Jan;25(1):5-8. doi: 10.1111/j.1755-148X.2011.00942.x. Review.

PMID:
22117610
2.

Modern genetics, ancient defenses, and potential therapies.

Gregersen PK.

N Engl J Med. 2007 Mar 22;356(12):1263-6. No abstract available.

PMID:
17377166
3.

Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.

Dwivedi M, Laddha NC, Mansuri MS, Marfatia YS, Begum R.

Br J Dermatol. 2013 Nov;169(5):1114-25. doi: 10.1111/bjd.12467.

PMID:
23773036
4.

Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.

Alkhateeb A, Qarqaz F.

Arch Dermatol Res. 2010 Oct;302(8):631-4. doi: 10.1007/s00403-010-1064-1.

PMID:
20574744
5.

NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.

Dieudé P, Guedj M, Wipff J, Ruiz B, Riemekasten G, Airo P, Melchers I, Hachulla E, Cerinic MM, Diot E, Hunzelmann N, Caramaschi P, Sibilia J, Tiev K, Mouthon L, Riccieri V, Cracowski JL, Carpentier PH, Distler J, Amoura Z, Tarner I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y.

Ann Rheum Dis. 2011 Apr;70(4):668-74. doi: 10.1136/ard.2010.131243.

PMID:
21149496
6.

NALP1 in vitiligo-associated multiple autoimmune disease.

Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA.

N Engl J Med. 2007 Mar 22;356(12):1216-25.

7.

Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease.

Alkhateeb A, Jarun Y, Tashtoush R.

Autoimmunity. 2013 May;46(3):215-21. doi: 10.3109/08916934.2013.768617.

PMID:
23374100
8.

Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.

Finger JN, Lich JD, Dare LC, Cook MN, Brown KK, Duraiswami C, Bertin J, Gough PJ.

J Biol Chem. 2012 Jul 20;287(30):25030-7. doi: 10.1074/jbc.M112.378323. Erratum in: J Biol Chem. 2012 Sep 7;287(37):31456. Bertin, John J [corrected to Bertin, John].

9.

Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease.

Horie Y, Saito W, Kitaichi N, Miura T, Ishida S, Ohno S.

Jpn J Ophthalmol. 2011 Jan;55(1):57-61. doi: 10.1007/s10384-010-0887-9.

PMID:
21331694
10.

NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.

Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA, Spritz RA.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2952-6. doi: 10.1073/pnas.1222808110.

11.

Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).

Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA.

J Invest Dermatol. 2010 Mar;130(3):774-83. doi: 10.1038/jid.2009.273.

12.

No evidence for association of the polymorphisms in NLRP1 gene with type 1 diabetes in Poland.

Zurawek M, Fichna M, Fichna P, Januszkiewicz D, Nowak J.

Diabetes Res Clin Pract. 2011 Jun;92(3):e49-51. doi: 10.1016/j.diabres.2011.02.004. No abstract available.

PMID:
21376416
13.

Genetic variations of NLRP1: susceptibility in psoriasis.

Ekman AK, Verma D, Fredrikson M, Bivik C, Enerbäck C.

Br J Dermatol. 2014 Dec;171(6):1517-20. doi: 10.1111/bjd.13178.

PMID:
24909542
14.

A coding variant in NLRP1 is associated with autoimmune Addison's disease.

Zurawek M, Fichna M, Januszkiewicz-Lewandowska D, Gryczyńska M, Fichna P, Nowak J.

Hum Immunol. 2010 May;71(5):530-4. doi: 10.1016/j.humimm.2010.02.004.

PMID:
20152874
15.

A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes.

Magitta NF, Bøe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE, Joner G, Njølstad PR, Kvien TK, Førre Ø, Knappskog PM, Husebye ES.

Genes Immun. 2009 Mar;10(2):120-4. doi: 10.1038/gene.2008.85.

PMID:
18946481
16.

Inflammatory caspases and inflammasomes: master switches of inflammation.

Martinon F, Tschopp J.

Cell Death Differ. 2007 Jan;14(1):10-22. Review.

17.

NLRP1 haplotypes associated with leprosy in Brazilian patients.

Pontillo A, Laurentino W, Crovella S, Pereira AC.

Infect Genet Evol. 2013 Oct;19:274-9. doi: 10.1016/j.meegid.2013.06.006.

PMID:
23770116
18.

Inflammasome activation and vitiligo/nonsegmental vitiligo progression.

Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, Picardo M, Taieb A, Ezzedine K, Cario-André M.

Br J Dermatol. 2014 Apr;170(4):816-23. doi: 10.1111/bjd.12691.

PMID:
24734946
19.

NALPs: a novel protein family involved in inflammation.

Tschopp J, Martinon F, Burns K.

Nat Rev Mol Cell Biol. 2003 Feb;4(2):95-104. Review.

PMID:
12563287
20.

Recent progress in the genetics of generalized vitiligo.

Spritz RA.

J Genet Genomics. 2011 Jul 20;38(7):271-8. doi: 10.1016/j.jgg.2011.05.005. Review.

Supplemental Content

Support Center